Li Wei, Ye Ziliang, Wang Wei, Wang Kun, Li Lang, Zhao Dewei
Zunyi Medical College, Guizhou, China.
Affiliated Zhongshan Hospital of Dalian University, Dalian, China.
Orthopade. 2017 May;46(5):440-446. doi: 10.1007/s00132-016-3360-8.
Although many clinical studies have shown that hyperbaric oxygen (HBO) therapy in the treatment of femoral head necrosis can significantly improve clinical symptoms and patients' quality of life, this conclusion has not been systematically evaluated. Therefore, a meta-analysis was performed to systematically evaluate the clinical effect of HBO therapy in the treatment of femoral head necrosis.
PubMed, Embase, and Web of Science databases, as well as the reference lists of relevant studies published before August 2016 were systematically searched using terms related to HBO and femoral head necrosis. Fixed or random effects models were used to estimate the pooled risk ratio (RR) with 95% confidence intervals (CI). Several subgroup analyses, sensitivity analyses, and publication bias tests were carried out to explore potential study heterogeneity and bias.
Nine studies involving 305 controls and 318 HBO cases were included. The clinical effect in the HBO therapy group was 4.95-times higher than in the control group (odds ratio, OR = 4.95, 95% CI [3.24,7.55], P < 0.00001) and the difference was statistically significant. According to the principle of subgroup analysis, the population was divided into Asian and non-Asian subpopulations. Subgroup analyses showed that the clinical effect in the HBO therapy group was 4.77-times higher than that of the control group of the Asian subpopulation (OR = 4.77, 95% CI [3.06,7.44], P < 0.00001) and 7.07-times than that of the control group of the non-Asian subpopulation (OR = 7.07, 95% CI [1.77,28.27], P < 0.00001).
The results of this study showed that HBO therapy can significantly improve the clinical treatment effect in patients with femoral head necrosis, and that this treatment approach is worthy of clinical application.
尽管许多临床研究表明高压氧(HBO)疗法在治疗股骨头坏死方面可显著改善临床症状和患者生活质量,但这一结论尚未得到系统评估。因此,进行了一项荟萃分析,以系统评估HBO疗法治疗股骨头坏死的临床效果。
使用与HBO和股骨头坏死相关的术语,对PubMed、Embase和Web of Science数据库以及2016年8月之前发表的相关研究的参考文献列表进行系统检索。采用固定或随机效应模型来估计合并风险比(RR)及95%置信区间(CI)。进行了多项亚组分析、敏感性分析和发表偏倚检验,以探讨潜在的研究异质性和偏倚。
纳入了9项研究,包括305名对照组和318名HBO治疗组患者。HBO治疗组的临床效果比对照组高4.95倍(优势比,OR = 4.95,95% CI [3.24,7.55],P < 0.00001),差异具有统计学意义。根据亚组分析原则,将人群分为亚洲和非亚洲亚组。亚组分析显示,HBO治疗组在亚洲亚组中的临床效果比对照组高4.77倍(OR = 4.77,95% CI [3.06,7.44],P < 0.00001),在非亚洲亚组中比对照组高7.07倍(OR = 7.07,95% CI [1.77,28.27],P < 0.00001)。
本研究结果表明,HBO疗法可显著提高股骨头坏死患者的临床治疗效果,该治疗方法值得临床应用。